A New Option for Therapeutic Management of Patients with Cardiovascular Disease: A Closer Look at the ONTARGET Study

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 2, 2008-01 ,pp. : 47-51

Adis International

Access to resources Recommend Favorite

Correction to the PRoFESS Trial Paper by Diener et al. (Cerebrovasc Dis 2007;23:368–380)

By  

Cerebrovascular Diseases, Vol. 25, Iss. 1-2, 2008-01 ,pp. : 192-192

Karger

Access to resources Recommend Favorite

Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)

By  

Cerebrovascular Diseases, Vol. 23, Iss. 5-6, 2007-02 ,pp. : 368-380

Karger

Access to resources Recommend Favorite

Sekundärprophylaxe des Schlaganfalls nach PRoFESS und SPARCL

By Sander D.  

Der Internist, Vol. 50, Iss. 11, 2009-11 ,pp. : 1227-1238

Springer Publishing Company

Access to resources Recommend Favorite

Discontinuation of Antiplatelet Study Medication and Risk of Recurrent Stroke and Cardiovascular Events: Results from the PRoFESS Study

By  

Cerebrovascular Diseases, Vol. 35, Iss. 6, 2013-06 ,pp. : 538-543

Karger

Access to resources Recommend Favorite